{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T04:54:49Z","timestamp":1769748889822,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.cbi.2023.110692","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T06:24:09Z","timestamp":1693549449000},"page":"110692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Insights into the mechanisms of telbivudine-induced myopathy associated with mitochondrial dysfunction"],"prefix":"10.1016","volume":"383","author":[{"given":"Wenfei","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuxun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanzhu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0861-5785","authenticated-orcid":false,"given":"Pengfei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2023.110692_bib1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/hep.32314","article-title":"Getting to HBV cure: the promising paths forward","volume":"76","author":"Fung","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2023.110692_bib2","first-page":"S45","volume":"603","author":"Brody","year":"2022","journal-title":"Hepatitis B, Nature"},{"key":"10.1016\/j.cbi.2023.110692_bib3","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.jhep.2005.11.020","article-title":"Assessment of treatment efficacy in HBV infection and disease","volume":"44","author":"Zoulim","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2023.110692_bib4","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/jmv.25566","article-title":"Efficacy and safety of telbivudine to prevent mother-to-child transmission of hepatitis B virus in middle- and late-stage pregnancy with high viral loads","volume":"91","author":"Xu","year":"2019","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cbi.2023.110692_bib5","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/j.gastro.2008.10.026","article-title":"2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B","volume":"136","author":"Liaw","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cbi.2023.110692_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1743-422X-7-323","article-title":"Myotoxicity of telbivudine in pre-existing muscle damage","volume":"7","author":"Finsterer","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.cbi.2023.110692_bib7","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1002\/hep.22885","article-title":"Side effects of long-term oral antiviral therapy for hepatitis B","volume":"49","author":"Fontana","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2023.110692_bib8","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/jclinpath-2013-202069","article-title":"Lamivudine\/telbivudine-associated neuromyopathy: neurogenic damage, mitochondrial dysfunction and mitochondrial DNA depletion","volume":"67","author":"Xu","year":"2014","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.cbi.2023.110692_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3988\/jcn.2023.19.1.52","article-title":"Telbivudine-induced myopathy: clinical features, histopathological characteristics, and risk factors","volume":"19","author":"Lan","year":"2023","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.cbi.2023.110692_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162760","article-title":"Clinicopathological features of telbivudine-associated myopathy","volume":"11","author":"Ambang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2023.110692_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2017.11.043","article-title":"Telbivudine attenuates UUO-induced renal fibrosis via TGF-\u03b2\/Smad and NF-\u03baB signaling","volume":"55","author":"Chen","year":"2018","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.cbi.2023.110692_bib12","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1128\/AAC.00029-08","article-title":"Nonclinical safety profile of telbivudine, a novel potent antiviral agent for treatment of hepatitis B","volume":"52","author":"Bridges","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cbi.2023.110692_bib13","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bcp.2017.10.005","article-title":"The Ca(2+)\/CaMKK2 axis mediates the telbivudine induced upregulation of creatine kinase: implications for mechanism of antiviral nucleoside analogs' side effect","volume":"146","author":"Jianfei","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2023.110692_bib14","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/hmg\/ddy107","article-title":"Leber's hereditary optic neuropathy (LHON)-associated ND5 12338T > C mutation altered the assembly and function of complex I, apoptosis and mitophagy","volume":"27","author":"Zhang","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cbi.2023.110692_bib15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF01753355","article-title":"Methods of microphotometric assay of succinate dehydrogenase and cytochrome c oxidase activities for use on human skeletal muscle","volume":"21","author":"Old","year":"1989","journal-title":"Histochem. J."},{"key":"10.1016\/j.cbi.2023.110692_bib16","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1038\/s41598-017-05571-y","article-title":"A novel ADOA-associated OPA1 mutation alters the mitochondrial function, membrane potential, ROS production and apoptosis","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2023.110692_bib17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nprot.2008.61","article-title":"Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells","volume":"3","author":"Kuznetsov","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.cbi.2023.110692_bib18","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1002\/mus.880181423","article-title":"Mitochondrial DNA mutation and muscle pathology in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes","volume":"3","author":"Mita","year":"1995","journal-title":"Muscle & nerve. Supplement"},{"key":"10.1016\/j.cbi.2023.110692_bib19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng0797-226","article-title":"A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart\/muscle isoform of the adenine nucleotide translocator","volume":"16","author":"Graham","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cbi.2023.110692_bib20","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.freeradbiomed.2013.06.027","article-title":"Free radical paradoxes","volume":"65","author":"Liochev","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2023.110692_bib21","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cbi.2023.110692_bib22","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1128\/AAC.46.6.1728-1733.2002","article-title":"Pharmacology of beta-L-thymidine and beta-L-2'-deoxycytidine in HepG2 cells and primary human hepatocytes: relevance to chemotherapeutic efficacy against hepatitis B virus","volume":"46","author":"Hernandez-Santiago","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cbi.2023.110692_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12325-009-0004-y","article-title":"Telbivudine in the treatment of chronic hepatitis B","volume":"26","author":"Nash","year":"2009","journal-title":"Adv. Ther."},{"key":"10.1016\/j.cbi.2023.110692_bib24","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jhep.2009.06.011","article-title":"Myopathy and neuropathy associated with nucleos(t)ide analog therapy for hepatitis B","volume":"51","author":"Fleischer","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2023.110692_bib25","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/ehf2.12341","article-title":"Telbivudine in chronic lymphocytic myocarditis and human parvovirus B19 transcriptional activity","volume":"5","author":"Van Linthout","year":"2018","journal-title":"ESC heart failure"},{"key":"10.1016\/j.cbi.2023.110692_bib26","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2005.02.010","article-title":"Antiviral drug-induced nephrotoxicity","volume":"45","author":"Izzedine","year":"2005","journal-title":"Am. J. Kidney Dis. : the official journal of the National Kidney Foundation"},{"key":"10.1016\/j.cbi.2023.110692_bib27","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/hupa.2001.25586","article-title":"Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion","volume":"32","author":"Tanji","year":"2001","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.cbi.2023.110692_bib28","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/ki.2010.344","article-title":"Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy","volume":"78","author":"Perazella","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.cbi.2023.110692_bib29","first-page":"513","article-title":"Tenofovir renal toxicity targets mitochondria of renal proximal tubules, Laboratory investigation","volume":"89","author":"Kohler","year":"2009","journal-title":"a journal of technical methods and pathology"},{"key":"10.1016\/j.cbi.2023.110692_bib30","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1007\/s10620-019-05717-0","article-title":"In Vitro and in vivo renoprotective effects of telbivudine in chronic hepatitis B patients receiving nucleotide analogue","volume":"64","author":"Mak","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.cbi.2023.110692_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105683","article-title":"Telbivudine antagonizes TLR4 to inhibit the epithelial-to-mesenchymal transition in human proximal tubular epithelial cells in vitro","volume":"74","author":"Chen","year":"2019","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.cbi.2023.110692_bib32","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM199004193221602","article-title":"Mitochondrial myopathy caused by long-term zidovudine therapy","volume":"322","author":"Dalakas","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2023.110692_bib33","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/135965350400900609","article-title":"Complications associated with NRTI therapy: update on clinical features and possible pathogenic mechanisms","volume":"9","author":"Nolan","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.cbi.2023.110692_bib34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1517\/14740338.2016.1139573","article-title":"DNA polymerase inhibitors for treating hepatitis B: a safety evaluation","volume":"15","author":"Mak","year":"2016","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.cbi.2023.110692_bib35","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.410170602","article-title":"Mitochondrial myopathies","volume":"17","author":"DiMauro","year":"1985","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cbi.2023.110692_bib36","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3389\/fgene.2019.00435","article-title":"Regulation of mitochondrial biogenesis as a way for active longevity: interaction between the Nrf2 and PGC-1\u03b1 signaling pathways","volume":"10","author":"Gureev","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.cbi.2023.110692_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67336-4","article-title":"Oxidative stress evaluation of skeletal muscle in ischemia-reperfusion injury using enhanced magnetic resonance imaging","volume":"10","author":"Kuroda","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2023.110692_bib38","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol. : CB (Curr. Biol.)"},{"key":"10.1016\/j.cbi.2023.110692_bib39","first-page":"8","article-title":"The role of signaling pathways of inflammation and oxidative stress in development of senescence and aging phenotypes in cardiovascular disease","author":"Papaconstantinou","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.cbi.2023.110692_bib40","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910674","article-title":"Myopathy reversion in mice after restauration of mitochondrial complex I","volume":"12","author":"Pereira","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cbi.2023.110692_bib41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s40478-020-01101-6","article-title":"Mitochondrial defects in the respiratory complex I contribute to impaired translational initiation via ROS and energy homeostasis in SMA motor neurons","volume":"8","author":"Thelen","year":"2020","journal-title":"Acta neuropathologica communications"},{"key":"10.1016\/j.cbi.2023.110692_bib42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0022-510X(88)90096-2","article-title":"Familial mitochondrial myopathy associated with peripheral neuropathy: partial deficiencies of complex I and complex IV","volume":"86","author":"Mizusawa","year":"1988","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cbi.2023.110692_bib43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jns.2015.08.1550","article-title":"A novel RRM2B gene variant associated with Telbivudine-induced mitochondrial myopathy","volume":"358","author":"Hern\u00e1ndez-La\u00edn","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cbi.2023.110692_bib44","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1750-1326-8-6","article-title":"Mitochondrial quality, dynamics and functional capacity in Parkinson's disease cybrid cell lines selected for Lewy body expression","volume":"8","author":"Cronin-Furman","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cbi.2023.110692_bib45","first-page":"2003","article-title":"Oxidative stress, mitochondrial damage and neurodegenerative diseases","volume":"8","author":"Guo","year":"2013","journal-title":"Neural Regen. Res."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279723003599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279723003599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T20:43:52Z","timestamp":1736369032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279723003599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":45,"alternative-id":["S0009279723003599"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2023.110692","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into the mechanisms of telbivudine-induced myopathy associated with mitochondrial dysfunction","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2023.110692","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110692"}}